Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma

Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as a part of highly active retroviral therapy for the treatment of infections of human immune deficiency virus type-1. A simple, sensitive and rapid reversed—phase high performance liquid chromatographic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Shweta, Kesarla, Rajesh, Chotai, Narendra, Omri, Abdelwahab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432066/
https://www.ncbi.nlm.nih.gov/pubmed/28505168
http://dx.doi.org/10.1371/journal.pone.0174777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432066/
https://www.ncbi.nlm.nih.gov/pubmed/28505168
http://dx.doi.org/10.1371/journal.pone.0174777

Ejemplares similares